Skip to main content
    P

    Privia Health Group Inc (PRVA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $25.26
    +0.71 (+2.89%)

    Market Cap: $3.14B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Privia Health Group Inc (PRVA) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Privia Health Group (PRVA) to earn $0.85 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.53B. Of 18 analysts, 17 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $1.03.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 18 ratings average 1.78, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 94% of the ratings.

    RatingAnalystsShare
    Strong Buy527.8%
    Buy1266.7%
    Hold15.6%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    18

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 21.2% and revenue estimates rise 9.5%.

    Fiscal year ending Dec 31, 2026
    $0.85
    EPS consensus, revenue $2.53B
    Fiscal year ending Dec 31, 2027
    $1.03
    EPS consensus, revenue $2.77B
    Next report
    Feb 24, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.85$0.77 to $1.2410$2.53B$2.45B to $2.56B14
    Dec 31, 2027$1.03$0.88 to $1.4010$2.77B$2.64B to $2.92B14

    Quarterly Estimates

    The EPS consensus rises from $0.12 for the quarter ending Dec 31, 2026 to $0.26 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.12$0.09 to $0.1620$653.55M$613.97M to $689.75M19
    Mar 31, 2027$0.26$0.20 to $0.335$665.12M$625.00M to $707.70M8

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 6 upward and 7 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202755
    Quarter ending Mar 31, 202712

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 8.6% from $0.93.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.85$0.89$0.89$0.88$0.93-8.2%
    Fiscal year ending Dec 31, 2027$1.03$1.06$1.06$1.06$1.08-4.9%
    Quarter ending Mar 31, 2027$0.26$0.31$0.31$0.31$0.30-15.4%

    Frequently Asked Questions About PRVA

    What is the PRVA stock forecast?

    Consensus analyst estimates put Privia Health Group's EPS at $0.85 for the fiscal year ending Dec 31, 2026, on revenue of $2.53B. The consensus rating from 18 analysts is Buy.

    How do analysts rate PRVA stock?

    Of 18 analysts covering Privia Health Group, 5 rate it Strong Buy, 12 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from PRVA next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.85, with estimates from $0.77 to $1.24 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.03, with estimates from $0.88 to $1.40 from 10 analysts.

    What revenue do analysts expect from Privia Health Group next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.53B, with estimates from $2.45B to $2.56B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.77B, with estimates from $2.64B to $2.92B.

    How many analysts cover PRVA?

    18 analysts rate Privia Health Group stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.